1276 — Jiangsu Hengrui Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$438.06bn
- HK$392.42bn
- CNY31.63bn
Annual cashflow statement for Jiangsu Hengrui Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -18,171 | -14,598 | -13,706 | -16,032 | -17,483 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,219 | 1,265 | 7,644 | 7,423 | 11,235 |
| Capital Expenditures | -1,665 | -1,992 | -1,484 | -1,969 | -2,962 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,118 | 2,382 | 2,706 | 57.2 | 221 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -546 | 390 | 1,222 | -1,912 | -2,741 |
| Financing Cash Flow Items | 67.9 | -563 | -862 | -276 | -1,282 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -998 | -319 | -3,144 | -1,551 | 7,782 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,657 | 1,417 | 5,734 | 3,968 | 15,916 |